{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":83,"description":"F-627, 20 mg fixed dose pre-filled syringe, dosed Day 2 of each of 4 chemotherapy cycles.","id":"EG000","otherNumAffected":17,"otherNumAtRisk":83,"seriousNumAffected":4,"seriousNumAtRisk":83,"title":"Cycle 1 F-627"},{"deathsNumAffected":0,"deathsNumAtRisk":39,"description":"Placebo, pre-filled syringe administered Day 2 of the first chemotherapy cycle 1","id":"EG001","otherNumAffected":5,"otherNumAtRisk":39,"seriousNumAffected":10,"seriousNumAtRisk":39,"title":"Cycle 1 Placebo"},{"deathsNumAffected":0,"deathsNumAtRisk":83,"description":"F-627, 20 mg fixed dose pre-filled syringe, dosed Day 2 of each of 4 chemotherapy cycles.","id":"EG002","otherNumAffected":26,"otherNumAtRisk":83,"seriousNumAffected":4,"seriousNumAtRisk":83,"title":"All 4 Cycles F-627"},{"deathsNumAffected":0,"deathsNumAtRisk":39,"description":"Placebo, pre-filled syringe administered Day 2 of the first chemotherapy cycle; and F-627, 20 mg fixed dose pre-filled syringe administered Day 2 of each of the following 3 chemotherapy cycles.","id":"EG003","otherNumAffected":9,"otherNumAtRisk":39,"seriousNumAffected":11,"seriousNumAtRisk":39,"title":"Cycle 1 Placebo and Cycle 2-4 F-627"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":83},{"groupId":"EG001","numAffected":1,"numAtRisk":39},{"groupId":"EG002","numAffected":8,"numAtRisk":83},{"groupId":"EG003","numAffected":3,"numAtRisk":39}],"term":"Nausea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":83},{"groupId":"EG001","numAffected":1,"numAtRisk":39},{"groupId":"EG002","numAffected":5,"numAtRisk":83},{"groupId":"EG003","numAffected":2,"numAtRisk":39}],"term":"Diarrhea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":83},{"groupId":"EG001","numAffected":2,"numAtRisk":39},{"groupId":"EG002","numAffected":4,"numAtRisk":83},{"groupId":"EG003","numAffected":2,"numAtRisk":39}],"term":"Stomatitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":83},{"groupId":"EG001","numAffected":0,"numAtRisk":39},{"groupId":"EG002","numAffected":5,"numAtRisk":83},{"groupId":"EG003","numAffected":1,"numAtRisk":39}],"term":"Bone pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":83},{"groupId":"EG001","numAffected":2,"numAtRisk":39},{"groupId":"EG002","numAffected":4,"numAtRisk":83},{"groupId":"EG003","numAffected":4,"numAtRisk":39}],"term":"Fatigue"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":83},{"groupId":"EG001","numAffected":10,"numAtRisk":39},{"groupId":"EG002","numAffected":3,"numAtRisk":83},{"groupId":"EG003","numAffected":11,"numAtRisk":39}],"term":"Febrile Neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":83},{"groupId":"EG001","numAffected":1,"numAtRisk":39},{"groupId":"EG002","numAffected":0,"numAtRisk":83},{"groupId":"EG003","numAffected":1,"numAtRisk":39}],"term":"Diarrhea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":83},{"groupId":"EG001","numAffected":0,"numAtRisk":39},{"groupId":"EG002","numAffected":0,"numAtRisk":83},{"groupId":"EG003","numAffected":1,"numAtRisk":39}],"term":"Pneumonia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":83},{"groupId":"EG001","numAffected":0,"numAtRisk":39},{"groupId":"EG002","numAffected":1,"numAtRisk":83},{"groupId":"EG003","numAffected":0,"numAtRisk":39}],"term":"Tumor hemorrhage"}],"timeFrame":"AEs and SAEs were collected from the time of randomization until 28 days after completion of the trial (a total of 16 weeks) or 28 days after premature withdrawal of a subject from the trial."}